• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Ishibashi Masumi  石橋 ますみ

ORCIDConnect your ORCID iD *help
… Alternative Names

ISHIBASHI Masumi  石橋 ますみ

Less
Researcher Number 20821383
Other IDs
Affiliation (Current) 2025: 東北大学, 大学病院, 講師
Affiliation (based on the past Project Information) *help 2024: 東北大学, 大学病院, 講師
2020 – 2023: 東北大学, 大学病院, 助教
2019: 東北大学, 医学系研究科, 大学院非常勤講師
2019: 東北大学, 医学系研究科, 非常勤講師
2018: 東北大学, 大学病院, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50010:Tumor biology-related / 0901:Oncology and related fields
Except Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related
Keywords
Principal Investigator
TIE-1 / PROTAC / 薬剤耐性 / ヌクレオチド除去修復 / DNA損傷修復機構 / 卵巣癌 / PI3K / DNA損傷修復 / シスプラチン / DNA repair / chemo-resistance / cisplatin … More
Except Principal Investigator
… More 卵巣癌 / セラミド / ネクロプトーシス / 循環腫瘍DNA / メタボローム / がんゲノム解析 / 婦人科がん / メタボロミクス / オミックス / バイオマーカー / 薬剤耐性 Less
  • Research Projects

    (4 results)
  • Research Products

    (5 results)
  • Co-Researchers

    (7 People)
  •  上皮性卵巣癌におけるネクロプトーシスの臨床的意義と治療標的としての可能性

    • Principal Investigator
      橋本 千明
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Tohoku University
  •  卵巣癌の新規治療標的 TIE-1 に対する PROTAC を用いた阻害剤の開発Principal Investigator

    • Principal Investigator
      石橋 ますみ
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Tohoku University
  •  Comprehensive genomic and transcriptome analyses to clarify molecular mechanisms contributing to chemoresistance in gynecologic cancer

    • Principal Investigator
      YAEGASHI Nobuo
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Tohoku University
  •  The molecular mechanism of Tyrosine kinase receptor TIE-1 as the therapeutic target for ovarian cancer.Principal Investigator

    • Principal Investigator
      ISHIBASHI Masumi
    • Project Period (FY)
      2018 – 2019
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Tohoku University

All 2022 2021

All Journal Article Presentation

  • [Journal Article] MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression2022

    • Author(s)
      Shigeta S, Watanabe Y, Suzuki F, Nagase S, Shibuya Y, Ishibashi M, Nagai T, Shiga N, Toyoshima M, Tokunaga H, Shimada M, Yaegashi N.
    • Journal Title

      Tohoku J. Exp. Med.

      Volume: 256 Issue: 3 Pages: 249-258

    • DOI

      10.1620/tjem.256.249

    • ISSN
      0040-8727, 1349-3329
    • Language
      English
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19H03795
  • [Journal Article] A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.2021

    • Author(s)
      Toyoshima M, Shimada M, Sasaki S, Ishibashi M, Shigeta S, Tsuji K, Nagai T, Tokunaga H, Niikura H, Yaegashi N.
    • Journal Title

      Tohoku J Exp Med.

      Volume: 254(3) Issue: 3 Pages: 145-153

    • DOI

      10.1620/tjem.254.145

    • NAID

      130008061848

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-17K11265
  • [Journal Article] CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.2021

    • Author(s)
      Oyama Y, Shigeta S, Tokunaga H, Tsuji K, Ishibashi M, Shibuya Y, Shimada M, Yasuda J, Yaegashi N.
    • Journal Title

      PLoS One.

      Volume: 16(6) Issue: 6 Pages: 0251079-0251079

    • DOI

      10.1371/journal.pone.0251079

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-19K09747, KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-20K18211
  • [Presentation] Development of TIE-1 target therapy for ovarian cancer2022

    • Author(s)
      石橋 ますみ
    • Organizer
      第74回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-22K15536
  • [Presentation] チロシンキナーゼ受容体型蛋白TIE-1の卵巣癌に対する抗腫瘍効果の検討2022

    • Author(s)
      石橋 ますみ
    • Organizer
      第64回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-22K15536
  • 1.  YAEGASHI Nobuo (00241597)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 2.  安田 純 (00281684)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 3.  島田 宗昭 (40362892)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 4.  徳永 英樹 (30595559)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 5.  橋本 千明 (50821625)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  重田 昌吾 (90842633)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  北谷 和之 (40539235)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi